These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

68 related items for PubMed ID: 8390428

  • 1. Effects of finasteride on the rat ventral prostate.
    Shao TC, Kong A, Marafelia P, Cunningham GR.
    J Androl; 1993; 14(2):79-86. PubMed ID: 8390428
    [Abstract] [Full Text] [Related]

  • 2. Influence of diethylstilbestrol, Leuprolelin (a luteinizing hormone-releasing hormone analog), Finasteride (a 5 alpha-reductase inhibitor), and castration on the lobar subdivisions of the rat prostate.
    Yamashita A, Hayashi N, Sugimura Y, Cunha GR, Kawamura J.
    Prostate; 1996 Jul; 29(1):1-14. PubMed ID: 8685049
    [Abstract] [Full Text] [Related]

  • 3. Differential effect of 5 alpha-reductase inhibition and castration on androgen-regulated gene expression in rat prostate.
    Rittmaster RS, Magor KE, Manning AP, Norman RW, Lazier CB.
    Mol Endocrinol; 1991 Jul; 5(7):1023-9. PubMed ID: 1719382
    [Abstract] [Full Text] [Related]

  • 4. Dutasteride, the dual 5alpha-reductase inhibitor, inhibits androgen action and promotes cell death in the LNCaP prostate cancer cell line.
    Lazier CB, Thomas LN, Douglas RC, Vessey JP, Rittmaster RS.
    Prostate; 2004 Feb 01; 58(2):130-44. PubMed ID: 14716738
    [Abstract] [Full Text] [Related]

  • 5. Effect of combination treatment with zanoterone (WIN 49596), a steroidal androgen receptor antagonist, and finasteride (MK-906), a steroidal 5 alpha-reductase inhibitor, on the prostate and testes of beagle dogs.
    Juniewicz PE, Hoekstra SJ, Lemp BM, Barbolt TA, Devin JA, Gauthier E, Frenette G, Dube JY, Tremblay RR.
    Endocrinology; 1993 Aug 01; 133(2):904-13. PubMed ID: 8393778
    [Abstract] [Full Text] [Related]

  • 6. Effects of castration on plasminogen activator activities and plasminogen activator inhibitor type 1 in the rat ventral prostate.
    Wilson MJ, Ludowese C, Sinha AA, Estensen RD.
    Prostate; 1996 Apr 01; 28(4):239-50. PubMed ID: 8602400
    [Abstract] [Full Text] [Related]

  • 7. Critical developmental periods for effects on male rat genitalia induced by finasteride, a 5 alpha-reductase inhibitor.
    Clark RL, Anderson CA, Prahalada S, Robertson RT, Lochry EA, Leonard YM, Stevens JL, Hoberman AM.
    Toxicol Appl Pharmacol; 1993 Mar 01; 119(1):34-40. PubMed ID: 8385814
    [Abstract] [Full Text] [Related]

  • 8. Pharmacologic basis for the enhanced efficacy of dutasteride against prostatic cancers.
    Xu Y, Dalrymple SL, Becker RE, Denmeade SR, Isaacs JT.
    Clin Cancer Res; 2006 Jul 01; 12(13):4072-9. PubMed ID: 16818707
    [Abstract] [Full Text] [Related]

  • 9. Relative potency of testosterone and dihydrotestosterone in preventing atrophy and apoptosis in the prostate of the castrated rat.
    Wright AS, Thomas LN, Douglas RC, Lazier CB, Rittmaster RS.
    J Clin Invest; 1996 Dec 01; 98(11):2558-63. PubMed ID: 8958218
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evidence for atrophy and apoptosis in the ventral prostate of rats given the 5 alpha-reductase inhibitor finasteride.
    Rittmaster RS, Manning AP, Wright AS, Thomas LN, Whitefield S, Norman RW, Lazier CB, Rowden G.
    Endocrinology; 1995 Feb 01; 136(2):741-8. PubMed ID: 7835306
    [Abstract] [Full Text] [Related]

  • 12. Effect of castration, DES, flutamide, and the 5 alpha-reductase inhibitor, MK-906, on the growth of the Dunning rat prostatic carcinoma, R-3327.
    Brooks JR, Berman C, Nguyen H, Prahalada S, Primka RL, Rasmusson GH, Slater EE.
    Prostate; 1991 Feb 01; 18(3):215-27. PubMed ID: 1850515
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Reduction of ventral prostate weight by finasteride is associated with suppression of insulin-like growth factor I (IGF-I) and IGF-I receptor genes and with an increase in IGF binding protein 3.
    Huynh H, Seyam RM, Brock GB.
    Cancer Res; 1998 Jan 15; 58(2):215-8. PubMed ID: 9443394
    [Abstract] [Full Text] [Related]

  • 15. The antigonadotropic action of testosterone but not 7alpha-methyl-19-nortestosterone is attenuated through the 5alpha-reductase pathway in the castrated male rat pituitary gland.
    Bandivdekar AH, Karp R, Sundaram K, Kumar N.
    J Androl; 2000 Jan 15; 21(2):268-75. PubMed ID: 10714822
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of microvessel densities in rat prostate tissues treated with finasteride, bicalutamide and surgical castration: a preliminary study.
    Kaya C, Ozyurek M, Turkeri LN.
    Int J Urol; 2005 Feb 15; 12(2):194-8. PubMed ID: 15733115
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of 5-alpha-reductase activity induces stromal remodeling and smooth muscle de-differentiation in adult gerbil ventral prostate.
    Corradi LS, Góes RM, Carvalho HF, Taboga SR.
    Differentiation; 2004 Jun 15; 72(5):198-208. PubMed ID: 15270776
    [Abstract] [Full Text] [Related]

  • 20. Expression of glutathione-peroxidase (GSH-PO) in the rat ventral prostate--effect of castration and administration of testosterone.
    Murakoshi M, Ikeda R, Tagawa M, Suzuki M, Takekoshi S, Watanabe K.
    Tokai J Exp Clin Med; 1997 Sep 15; 22(3):111-8. PubMed ID: 9618832
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.